Hypertrophic cardiomyopathy

Board exam relevance: in 3 of more than 100 exam reports · rank 111
Synonyms
HCM, HOCM, hypertrophic obstructive cardiomyopathy, thickened heart muscle
Specialty
Internal medicine · Cardiology
Images
Echocardiography 1
Last updated
10/2026 · Dr. Pascal Bafteh
Contents
  1. Images (1)
  2. Definition
  3. Classification
  4. Occurrence & epidemiology
  5. Aetiopathogenesis
  6. Clinical features
  7. Histology
  8. Diagnosis
  9. Treatment principles
  10. Keep learning in the app
  11. Further reading (open access)
  12. Cross-references

Images (1)

Hypertrophic cardiomyopathy – Continuous-wave Doppler in the outflow tract: late-peaking, dagger-shaped signal (about 4 m/s) indicating dynamic obstruction in HOCMEchocardiography
Continuous-wave Doppler in the outflow tract: late-peaking, dagger-shaped signal (about 4 m/s) indicating dynamic obstruction in HOCMImage: CardioNetworks: Secretariat, “HOCM with SAM E00517 (CardioNetworks ECHOpedia)” (Wikimedia Commons) · CC BY-SA 3.0 · Source · cropped

Definition

Hypertrophic cardiomyopathy (HCM) is a mostly genetic myocardial disorder with left ventricular hypertrophy. In adults a maximal diastolic wall thickness of 15 mm or more (echocardiography or MRI) without an alternative cause is considered diagnostic; with a family history or a proven pathogenic sarcomeric variant a threshold of 13 mm or more is sufficient. This differs from hypertrophy due to pressure overload (e.g. aortic stenosis, hypertension).

Classification

  • Obstructive HCM (HOCM): peak left ventricular outflow tract (LVOT) gradient of 30 mmHg or more at rest or with physiological provocation; gradients of 50 mmHg or more are generally considered sufficient to cause symptoms.
  • Non-obstructive HCM.
  • Morphology: most commonly asymmetric hypertrophy of the basal septum; also focal or symmetric forms, apical HCM (without outflow tract obstruction, more common in people of Asian descent) and midventricular obstruction, often with an apical aneurysm.

Occurrence & epidemiology

HCM is the most common monogenic cardiac disorder, with an estimated prevalence of 1:200 to 1:500 adults. About two-thirds of patients have dynamic outflow tract obstruction. Symptoms usually appear in early to mid-adulthood (30s to 50s).

Aetiopathogenesis

  • Genetics: pathogenic variants in genes of the cardiac sarcomere, most frequently MYBPC3 and MYH7, are found in about 35 % of tested patients with clinical HCM; penetrance and expression vary markedly.
  • Phenocopies: Fabry disease, Danon disease, Andersen disease and other glycogen storage diseases can mimic HCM.
  • Pathophysiology: excessive actin-myosin cross-bridge formation and abnormal calcium handling cause hypercontractility and reduced compliance. The stiff chamber fills poorly, and end-diastolic and pulmonary venous pressures rise.
  • Outflow tract obstruction: interplay of the thickened basal septum and systolic anterior motion (SAM) of the often elongated anterior mitral leaflet, with accompanying posteriorly directed mitral regurgitation.
  • Ischemia despite normal epicardial coronary arteries due to microvascular dysfunction, capillary-myocyte mismatch and increased oxygen demand.

Clinical features

  • Highly variable presentation; symptoms frequently on exertion: dyspnea, chest pain (usually resembling typical angina), palpitations, syncope.
  • Exertional syncope results from outflow tract obstruction or arrhythmia and is an important warning sign of sudden cardiac death.
  • Symptoms are aggravated by conditions that reduce preload or afterload and increase heart rate and contractility.
  • Auscultation: dynamic late-peaking systolic murmur at the left sternal border in the 3rd or 4th intercostal space; louder with the Valsalva maneuver and on standing up from squatting, softer with handgrip, prolonged squatting or passive leg raising; possibly an additional mitral regurgitation murmur at the apex; often a fourth heart sound.
  • Pulse: with obstruction a brisk upstroke, bifid peak and rapid downstroke; sustained apex beat; blood pressure and heart rate usually normal.

Histology

Classic findings are cardiomyocyte hypertrophy, disorganized arrangement of myocytes ("myocyte disarray"), interstitial fibrosis and thick-walled intramural coronary arteries.

Diagnosis

  • History: syncope and other symptoms; three-generation family history (HCM, unexplained sudden cardiac death).
  • Echocardiography: extent and distribution of hypertrophy, outflow tract gradient at rest and with provocation, systolic anterior motion of the mitral valve, mitral regurgitation; usually a small cavity with normal or hyperdynamic systolic function.
  • Cardiac MRI: precise wall thickness measurement including segments difficult to visualise; apical aneurysms; late gadolinium enhancement reflecting fibrosis.
  • ECG: frequently left ventricular hypertrophy with repolarisation abnormalities (deep T-wave inversion, ST depression), Q waves, signs of left atrial enlargement; sometimes bundle branch block or pre-excitation.
  • Ambulatory ECG over 24–48 hours: atrial arrhythmias and ventricular tachycardia (a risk factor).
  • Exercise testing: provocation of outflow tract obstruction, functional capacity.
  • Chest X-ray: often normal, possibly an enlarged left atrium.
  • Genetic testing and examination of relatives.

Treatment principles

  • In symptomatic obstructive disease, beta blockers or non-dihydropyridine calcium channel blockers are first-line; vasodilators and hypovolaemia are avoided.
  • For refractory symptoms, cardiac myosin inhibitors or septal reduction by myectomy or alcohol septal ablation are options.
  • To prevent sudden cardiac death, risk is stratified individually and an ICD is implanted where indicated; genetic family screening is part of management.

Specific treatment regimens with drugs and doses are covered in the InnereFuchs app.

Keep learning in the app

In the InnereFuchs app you can learn Hypertrophic cardiomyopathy with flashcards, exam questions and image tasks (ECG, chest X-ray, ultrasound, lab values) – free, in your browser or as an app.

Open in browser  About InnereFuchs →

Further reading (open access)

  1. MSD Manual Professional: Hypertrophic Cardiomyopathy
  2. StatPearls: Hypertrophic Cardiomyopathy

Cross-references

Keep learning

Keep learning with flashcards, exam questions and spot diagnoses in the InnereFuchs app – free, in your browser or as an app.

Related pages: Acute coronary syndrome (heart attack, STEMI/NSTEMI) · Heart failure · Atrial fibrillation

Note: Learning content for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.